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Abstract 
Background: Ethiopia has set a goal for malaria elimination by 2030. Low parasite density infections may go unde-
tected by conventional diagnostic methods (microscopy and rapid diagnostic tests) and their contribution to malaria 
transmission varies by transmission settings. This study quantified the burden of subpatent infections from samples 
collected from three regions of northwest Ethiopia.
Methods: Sub-samples of dried blood spots from the Ethiopian Malaria Indicator Survey 2015 (EMIS-2015) were 
tested and compared using microscopy, rapid diagnostic tests (RDTs), and nested polymerase chain reaction (nPCR) 
to determine the prevalence of subpatent infection. Paired seroprevalence results previously reported along with 
gender, age, and elevation of residence were explored as risk factors for Plasmodium infection.
Results: Of the 2608 samples collected, the highest positive rate for Plasmodium infection was found with nPCR 3.3% 
(95% CI 2.7–4.1) compared with RDT 2.8% (95% CI 2.2–3.5) and microscopy 1.2% (95% CI 0.8–1.7). Of the nPCR positive 
cases, Plasmodium falciparum accounted for 3.1% (95% CI 2.5–3.8), Plasmodium vivax 0.4% (95% CI 0.2–0.7), mixed P. 
falciparum and P. vivax 0.1% (95% CI 0.0–0.4), and mixed P. falciparum and Plasmodium malariae 0.1% (95% CI 0.0–0.3). 
nPCR detected an additional 30 samples that had not been detected by conventional methods. The majority of the 
nPCR positive cases (61% (53/87)) were from the Benishangul-Gumuz Region. Malaria seropositivity had significant 
association with nPCR positivity [adjusted OR 10.0 (95% CI 3.2–29.4), P < 0.001].
Conclusion: Using nPCR the detection rate of malaria parasites increased by nearly threefold over rates based on 
microscopy in samples collected during a national cross-sectional survey in 2015 in Ethiopia. Such subpatent infec-
tions might contribute to malaria transmission. In addition to strengthening routine surveillance systems, malaria pro-
grammes may need to consider low-density, subpatent infections in order to accelerate malaria elimination efforts.
Keywords: Subpatent infections, Asymptomatic infections, Sub microscopic infections, Malaria, Ethiopia
© The Author(s) 2020. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, 
adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and 
the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material 
in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material 
is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the 
permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creat iveco 
mmons .org/licen ses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creat iveco mmons .org/publi cdoma in/
zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
Background
The Global Technical Strategy for Malaria of the World 
Health Organization (WHO) calls for a world free of 
malaria [1]. To contribute to this global vision and 
encouraged by the substantial gains made in malaria con-
trol over the last two decades, Ethiopia has embarked 
on progressively eliminating malaria starting from low 
malaria transmission areas [2–6]. In the initial phase, 
239 woredas (districts) were targeted for malaria elimi-
nation by the National Malaria Control and Elimination 
Programme of Ethiopia [5]. Preparations are under-
way to shift diagnosis and surveillance approaches from 
reducing malaria morbidity and mortality to detecting 
Open Access
Malaria Journal
*Correspondence:  ashyaega@yahoo.com
1 Ethiopian Public Health Institute, Arbegnoch Street, Mail Box: 19922, 
Addis Ababa, Ethiopia
Full list of author information is available at the end of the article
Page 2 of 10Assefa et al. Malar J          (2020) 19:108 
infections and measuring transmission in the selected 
woredas [2, 5].
Malaria elimination requires the detection and clear-
ing of all Plasmodium infections. A relatively high prev-
alence of subpatent or low parasite density infections, 
that are often missed by conventional diagnostic meth-
ods (microscopy and rapid diagnostic tests) are being 
reported especially from low transmission settings [7–
14]. Such asymptomatic, subpatent infections could be 
explained by acquired immunity in higher transmission 
settings [15]. Even in low transmission settings, asymp-
tomatic and subpatent infections might play a role in 
transmission dynamics, hindering the progress of malaria 
elimination [14–19].
In Ethiopia, Plasmodium falciparum and Plasmodium 
vivax are the major reported malaria parasite species 
with rare reports of Plasmodium malariae and Plasmo-
dium ovale. In 2017, out of a total confirmed malaria 
cases of 1,530,739, P. falciparum accounted for 1,059,847 
cases and P. vivax for 470,892 cases [1, 2].
The current study assessed the magnitude of subpat-
ent infections in northwestern Ethiopia, using samples 
collected in 2015 from a nationwide household survey of 
malaria endemic areas.
Methods
Study area
The study used Dried blood spot (DBS) samples col-
lected as part of the National Ethiopian Malaria Indi-
cator Survey conducted in 2015 (EMIS-2015) [20]. The 
survey was conducted during the peak of the malaria 
transmission season between September and Decem-
ber, 2015. Sample collection during EMIS-2015 was 
limited to areas below 2500  m elevation, with 85% of 
samples collected from areas below 2000  m elevation 
and the remaining 15% from areas between 2000 and 
2500 m elevation. For the present study, samples were 
selected purposefully from the Amhara, Benishangul-
Gumuz and Tigray Regions (Fig.  1). From the EMIS-
2015 results, rapid diagnostic test (RDT) prevalence 
ranged from 10.4% in Benishangul-Gumuz, 1.9% in 
Tigray, to 1.1% in Amhara. A separate study [21] also 
found this geographical area to represent a range of 
malaria transmission from very low to moderate based 
on seroprevalence. Participants tested by malaria 
microscopy and RDT that provided DBS samples were 
selected from the EMIS 2015 samples repository at 
the Ethiopian Public Health Institute (EPHI) in Addis 
Ababa, Ethiopia.
Fig. 1 Ethiopia and location of the three sample collection regions (shaded grey): Tigray, Amhara and Benishangul-Gumuz
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Study population and sample collection
EMIS-2015 was a cross-sectional survey, which used a 
two-stage cluster sampling methodology [20]. Enumera-
tion Areas (EA), the sampling unit, were selected propor-
tional to population size and 25 households were selected 
by simple random sampling from each EA. Demographic, 
socioeconomic, malaria prevention, and malariometric 
data were also collected in the selected households. All 
children under 5 years of age in selected households and 
persons of all ages in every 4th household were eligible 
for biological sample collection and testing [20]. Whole 
blood from a single finger prick from consenting indi-
viduals (with or without fever) was collected for Plasmo-
dium infection identification by RDT and microscopy, 
haemoglobin testing (Hemocue Hb 201+, Hemocue AB, 
Ängelholm, Sweden) and for collection of DBS samples. 
Whatman 903 (GE Healthcare, Pittsburgh, PA) filter 
paper cards were used for DBS collection. These were air 
dried, individually packed in a plastic bag together with a 
desiccant and stored at − 20 °C at EPHI before they were 
sent to the U.S. Centers for Disease Control and Preven-
tion (CDC) in, Atlanta, Georgia, for processing.
Plasmodium infection exposure
Serology methods and results for these samples have 
been previously reported [21]. Briefly, DBS elutions were 
assayed using bead-based multiplex assays for IgG anti-
bodies for six.
Plasmodium antigens: four human malaria species-spe-
cific merozoite surface protein-1 19 kD antigens (MSP-1) 
and Apical membrane antigen-1 (AMA-1) for P. falcipa-
rum and P. vivax.
Parasite identification
Rapid diagnostic tests
The CareStart™ Malaria HRP2/pLDH (Pf/PAN) Combo 
RDT were used to detect malaria in the field. CareStart™ 
tests for histidine-rich protein 2 (HRP2) to detect P. fal-
ciparum and pan-Plasmodium lactose dehydrogenase 
(LDH) for P. falciparum, P. vivax, P. ovale and P. malariae.
Microscopy
Thick and thin blood smears were made on the same 
slide, air-dried, and transported to EPHI. The slides were 
stained with 3% Giemsa for 10 min and screened for the 
presence of plasmodial infections. Microscopists were 
WHO certified and were blinded to the RDT and sur-
vey results. A slide was classified as negative if no Plas-
modium asexual forms or gametocytes were found after 
viewing 100 fields. Any positive slide was confirmed by 
two other microscopists.
Polymerase chain reaction
The DBSs were shipped to CDC at ambient temperature. 
A total of 2533 RDT-negative and 2 samples without RDT 
results available from the three regions were pooled and 
analysed (Fig. 2). An additional 73 RDT-positive samples 
were analysed and confirmed by PCR individually.
Two-step pooling was used to estimate the prevalence 
of malaria in the RDT-negative samples, as previously 
Fig. 2 Flow chart showing sampling and pooling analysis procedures
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described by Zhou et al. [23]. A pilot was carried out to 
test for the effect of age (pooled by less than or equal 
to five and above 5  years of age) and different numbers 
of sample pooling (five or ten samples per pool), but no 
major differences by age or pooling size were found. Sub-
sequently, individual samples from the same region were 
randomized into pools of ten samples.
DNA extraction A 6-mm disk was punched out from 
each DBS card and ten disks pooled for DNA extraction. 
Pooled DBSs were extracted with QIAamp DNA Mini 
kit as per the manufacturer’s protocol (QIAGEN, Valen-
cia, CA) with slight modification. Samples were left for 
an overnight incubation in ATL buffer plus Proteinase K 
to ensure proper lysis during pooling, and the DNA was 
then extracted following a normal extraction protocol. 
The purified DNA was tested using nested genus PCR 
(nPCR). For any pool with a positive PCR result, individ-
ual DBSs were extracted following the same protocol as 
for the pooled samples and species-specific PCR assays 
were performed.
nPCR detection for  18S ribosome RNA (rRNA) Puri-
fied DNA templates were used for amplification of the 
18S rRNA gene subunit using a modified method as pre-
viously described [23]. Briefly, the 25  μL PCR reaction 
contained 1× PCR Master Mix (Promega, Madison, WI) 
and 100 nM of each PCR primer. For each primary PCR 
reaction, 5 μL of DNA were used. The reactions were per-
formed under the conditions of initial denaturation at 
95  °C for 5 min, 25 cycles at 95  °C for 1 min, annealing 
at 58 °C for 2 min, and final extension at 72 °C for 2 min, 
followed by a final extension at 72 °C for 10 min. Species 
PCR was performed as per primary PCR except for use of 
35 cycles and 2.5 μL primary PCR product per reaction. 
Genus PCR was performed as per species PCR except 
annealing temperature was set at 64  °C. The amplified 
DNA products were stained with GelRed (Biotium, Hay-
ward, CA), separated using 2% agarose gel electrophoresis 
and visualized under UV illumination.
Data analysis
Data were analysed using Stata 13 (Stata Corp. 2015. 
Stata Statistical Software: Release 14. College Station, TX: 
Stata Corp LP, USA). Descriptive statistics with 95% con-
fidence interval were estimated for demographic charac-
teristics. Multiple logistic regression was used to assess 
the association of risk factors (gender, age, elevation, 
bed net use and seropositivity) with nPCR parasitae-
mia results. Percent relative difference and concordance 
for microscopy and RDTs were calculated against PCR 
results as the reference standard. Values were considered 
significant at P < 0.05. A Venn diagram was constructed 
using STATA to visualize the relationship amongst the 
four diagnostic methods: microscopy, RDTs, nPCR and 
serology. QGIS 2.18 was used to construct a map of the 
study area.
Results
Study population
Of the 2669 samples available from the three regions, 
2535 samples were pooled for PCR analysis and 73 tested 
individually: 945 from Amhara, 668 from Benishangul-
Gumuz and 922 from Tigray (Fig. 2). A total of 2608 sam-
ples had matched assay and survey data, comprising of 
2533 RDT-negative, 73 RDT-positive and 2 without RDT 
results. About 53% (95% CI 50.4–54.2) of the samples 
tested were from females and 44% (95% CI 42.0–45.8) 
from children under 5 years of age (Table 1). The mean 
participant age from the samples was 16.1 years (95% CI 
15.4–17.0) (range: 1–88  years). About 80% of the data 
were collected from areas below 2000 m in elevation. Of 
the 1354 samples with a paired seroprevalence result, 
almost half [51.3% (95% CI 48.6–53.9)] were seropositive 
of which 41.3% (95% CI 38.7–43.9) of the samples were 
seropositive for P. falciparum (MSP-1 or AMA-1 antigen 
responses) and 34.0% (95% CI 31.6–36.6) seropositive for 
Table 1 Characteristics of  survey samples from  Tigray, 
Amhara and  Benishangul-Gumuz Regions of  Ethiopia, 
2015
Characteristics Number Proportion (%) (95% CI)
Sex N = 2608
 Female 1364 52.3 (50.4–54.2)
 Male 1244 47.7 (45.8–49.6)
Age N = 2608
 < 5 1145 43.6 (42.0–45.8)
 5–14 years 508 19.5 (18.0–21.0)
 15–24 years 325 12.5 (11.2–13.8)
 25–49 years 460 17.6 (16.2–19.1)
 > 50 years 170 6.5 (5.6–7.5)
Elevation N = 2608
 < 2000 m 2134 81.8 (80.3–83.3)
 ≥ 2000 m 474 18.2 (16.7–19.7)
Use of bed nets N = 1798
 Yes 1072 59.6 (57.3–61.9)
 No 726 40.4 (38.1–42.7)
Seropositivity N = 1354
 P. falciparum (MSP-1 or AMA-1) 559 41.3 (38.7–43.9)
 P. vivax (MSP-1 or AMA-1) 461 34.0 (31.6–36.6)
 P. malariae (MSP-1) 94 7.0 (5.7–8.4)
 P. ovale (MSP-1) 66 4.9 (3.8–6.2)
 Any Plasmodium (MSP-1 or 
AMA-1)
694 51.3 (48.6–53.9)
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P. vivax (MSP-1 or AMA-1). Additionally, 7.0% (95% CI 
5.7–8.4) and 4.9% (95% CI 3.8–6.2) of participants were 
seropositive for P. malariae and P. ovale MSP-1 antigen 
responses, respectively. Overall, 59.6% (95% CI 57.3–
61.9) of respondents providing samples reported having 
slept under a bed net in the previous night (Table 1).
Prevalence of malaria infection
The detection of Plasmodium infection varied by diag-
nostic methods: microscopy, RDT and nPCR (Table  2). 
Of the 2608 samples tested 2.8% (95% CI 2.2–3.5) were 
found to be positive for Plasmodium using RDTs, com-
prising of 1.9% (95% CI 1.5–2.5) due to P. falciparum 
(only HRP2 positive), 0.4% (95% CI 0.2–0.7) due to P. 
falciparum infection with or without other Plasmodium 
species (HRP2 and panLDH positive) and 0.5% (95% CI 
0.3–0.5) were P. vivax, P. ovale or P. malariae infection 
(only panLDH positive). Using microscopy, 1.2% (95% 
CI 0.8–1.7) of the samples were found to be positive for 
Plasmodium, of which 1.0% (95% CI 0.6–1.4) were due to 
P. falciparum infection, 0.2% (95% CI 0.0–0.4) were due 
to P. vivax infection and 0.08% (95% CI 0.0–0.3) were due 
to mixed P. falciparum and P. vivax infection. RDT posi-
tivity was over twofold higher than microscopy positiv-
ity (Table 2). Figure 3 shows the relationships and overlap 
among serology, RDTs, microscopy and nPCR methods.
Malaria DNA screening by nPCR detected 3.3% (95% 
CI 2.7–4.1) positivity for any malaria species. Of this, P. 
falciparum accounted for 3.1% (95% CI 2.5–3.8) of infec-
tion, P. vivax accounted for 0.4% (95% CI 0.2–0.7) of 
infection, mixed P. falciparum and P. vivax 0.1% (95% CI 
0.0–0.4), and mixed P. falciparum and P. malariae 0.1% 
(95% CI 0.0–0.3). PCR detected 64.4% and 16.1% more 
positives compared to microscopy and RDT, respec-
tively (P < 0.05). In addition, PCR detected two P. malar-
iae cases mixed with P. falciparum cases. By RDT, these 
were both appropriately positive for HRP2 and pan-
LDH antigens. Using microscopy, one of the P. malariae 
positive infection was missed and the other was identi-
fied as mixed infection. No P. ovale infection was iden-
tified by any diagnostic method (Table  2). Seropositive 
samples had a very high likelihood of being screened 
positive for malaria DNA [adjusted OR 10.0 (95% CI 
3.2–29.4; P < 0.001)]. While living in lower elevation areas 
(< 2000 m), sex, age group, or bed net use were not asso-
ciated with PCR positivity in the study samples (Table 3).
PCR identified 30 additional samples as positive that 
were negative by RDT (Table  4). Of these, 25 were due 
to P. falciparum infection, five were due to P. vivax infec-
tion, and two were due to a mixed infection of P. falci-
parum and P. malariae. Half of the additional positive 
samples (14 of 30), and mixed P. falciparum and P. malar-
iae cases were identified from samples collected in Benis-
hangul-Gumuz, a region of higher malaria transmission 
in Ethiopia.
The percent concordance of RDTs and microscopy 
with nPCR detection on sample positivity varied between 
the three regions (Table  5). Overall, 80.8% (59/73) of 
the samples identified as positive by RDTs and 83.9% by 
microscopy were confirmed positive by nPCR. The high-
est agreement with nPCR data for both RDTs (90.7%) and 
microscopy (86.7%) was observed in the Benishangul-
Gumuz samples where P. falciparum is predominant. In 
the Amhara and Tigray regions agreement with nPCR 
diagnosis was lower at 64.3% and 68.8%, respectively.
Table 2 Variation in malaria positivity of samples between RDT, microscopy and nPCR in the study area (Tigray, Amhara 
and Benishangul-Gumuz Regions), 2015
Diagnostic methods Species diagnosed Number 
of positives
Percent positivity 
(95% CI)
Percent 
relative change 
from PCR
RDT (n = 2606) P. falciparum (HRP2+) 50 1.9 (1.5–2.5) − 37.5
P. vivax/P. malariae/P. ovale (panLDH+) 12 0.5 (0.3–0.8) 0.0
P. falciparum or mixed (HRP2 and panLDH+) 11 0.4 (0.2–0.7) N/A
Total Plasmodium positive 73 2.8 (2.2–3.5) − 16.1
Microscopy (n = 2605) P. falciparum 25 1.0 (0.6—1.4) − 68.8
P. vivax 4 0.2 (0.0–0.4) − 60.0
Mixed P. falciparum + P. vivax 2 0.08 (0.0–.03) − 33.3
Total Plasmodium positive 31 1.2 (0.8–1.7) − 64.4
nPCR (n = 2608) P. falciparum monoinfection 80 3.1 (2.5–3.8)
P. vivax monoinfection 10 0.4 (0.2–0.7)
Mixed P. falciparum + P. vivax 3 0.1 (0.0–0.4)
Mixed P. falciparum + P. malariae 2 0.07 (0.0–0.3)
Total Plasmodium positive 87 3.3 (2.7–4.1)
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Fig. 3 Venn diagram showing the relationships and overlap among serology (IgG MSP-1 or AMA-1), Rapid Diagnostic Tests (RDTs), Microscopy and 
nested Polymerase Chain Reaction (nPCR) methods, in 1522 samples with complete results collected from Tigray, Amhara and Benishangul-Gumuz 
Regions, Ethiopia as part of the Malaria Indicator Survey, 2015
Table 3 Association between  nPCR positivity and  sample characteristics (sex, age, elevation, bed net use 
and seropositivity)
PCR positive
Unadjusted OR (95% CI) P-value Adjusted OR (95% CI) P-value
Sex
 Female Ref Ref
 Male 1.3 (0.8–2.0) 0.231 0.8 (0.5–1.2) 0.21
Age intervals (years)
 < 5 Ref Ref
 5–14 1.2 (0.5–2.9) 0.758 1.3 (0.5–3.4) 0.535
 15–24 1.0 (0.3–3.1) 0.974 1.3 (0.4–3.6) 0.702
 25–49 0.5 (0.2–1.9) 0.343 0.7 (0.2–3.9) 0.528
 ≥ 50 0.4 (0.1–3.2) 0.407 0.5 (0.1–3.9) 0.512
Elevation (m)
 > 2000 Ref Ref
 < 2000 7.2 (1.0–53.5) 0.052 5.0 (0.1–53.7) 0.118
Use of bed net (N = 1798)
 No Ref Ref
 Yes 0.7 (0.4–1.3) 0.267 0.8 (0.4–1.3) 0.345 
Seropositivity
 No Ref Ref
 Yes 5.9 (2.0–17.1) 0.001 10.0 (3.2–29.4) < 0.001
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Discussion
In this study, results of microscopy, RDT and nPCR 
detection methods were used to examine the prevalence 
of Plasmodium infection in malaria endemic settings in 
northwest Ethiopia. Nested PCR identified 30 additional 
positive malaria infections that were missed by RDTs in 
the field, and thus not provided treatment at the time of 
the survey. The prevalence reported by nPCR was 3.3%, 
16.1% higher than that detected by RDTs and 64.4% 
higher than from microscopy. More than 60% of the 
nPCR positive cases were identified from Benishangul-
Gumuz Region, which is one of the higher malaria 
transmission region in Ethiopia [5]. The region showed 
a similar high prevalence of malaria by microscopy and 
RDTs in this study and in a separate serology study of the 
same samples [21].
The study compared microscopy and RDT detec-
tion methods with a pooling nPCR approach that can 
detect parasite density as low as 0.1–10 parasites/µl of 
blood [22–26]. Close agreement was observed between 
both RDT and microscopy results compared to PCR 
with 80.8% and 83.9% concordance, respectively. 
Microscopy, considered the gold standard for malaria 
diagnosis [26], has a variable limit of detection (50–
100  parasite/µl of blood) [26–28], depending on the 
skill of the technician and the reagents used [26–28]. As 
per the national malaria diagnosis and treatment guide-
line [29], Ethiopia uses microscopy in health centres 
and hospitals and RDTs in health posts (primary health 
care units). In the current study with slide prepara-
tion and RDTs conducted under field conditions where 
test requirements may not be optimal, high variability 
was observed in the results across the three methods. 
This discordance becomes disproportionately higher in 
these low transmission settings with very few positive 
samples. The strong association between seropositivity 
and PCR positivity suggests a role for using multiplex 
seroprevalence results to more rapidly and inexpen-
sively identify hotspots or confirm lack of Plasmodium 
infection in areas reporting low incidence.
Although the lower RDT positivity is likely due to 
low-density infections, the possibility of hrp2/3 gene 
deleted P. falciparum infections has been raised in 
Ethiopia with alarming reports originating from Eri-
trea [29–33]. Although HRP2 and HRP3 deletions 
were reported recently from a study in Amhara [34], 
a study of larger geographic scope is currently ongo-
ing in Ethiopia (Sindew Mekasha, EPHI, personal 
communication).
Several studies have reported asymptomatic Plas-
modium infections in low transmission settings using 
PCR from a range of countries [7–15, 18, 22, 35, 36]. 
The terms asymptomatic, submicroscopic, and subpat-
ent are often used interchangeably to describe a malaria 
infection that cannot be detected by conventional 
methods (microscopy and RDTs) but can be detected 
by more sensitive methods such as PCR. The prevalence 
of subpatent infection in low transmission setting has 
ranged from 0.003 to 44%, depending on the sensitivity 
of the tools used and the sample collection area [36]. 
Studies in Iran [37] and Sri Lanka [38] reported zero 
prevalence by the more sensitive methods, indicative 
of no local transmission and confirmation of malaria 
elimination. Golassa et  al. [14] and Tadesse et  al. [15] 
reported PCR prevalence ranging from 1.7 to 5.8% in 
southwest Ethiopia, comparable to the 3.3% prevalence 
reported in the current study.
Subpatent infections, despite the low parasite den-
sity, could be infectious to mosquitoes [15, 19, 39]. 
Table 4 Malaria prevalence by nPCR from RDT-negative samples by region, 2015 EMIS
73 samples that were RDT positive and 2 samples from Amhara and Tigray each not tested by RDT were excluded
a Mixed with P. falciparum
Region RDT negative 
samples
PCR-positive samples
P. falciparum P. vivax P. malariae P. ovale Total positive, % (n)
Benishangul- Gumuz 668 12 2 2a 0 2.1% (14)
Amhara 944 8 2 0 0 1.1% (10)
Tigray 921 5 1 0 0 0.7% (6)
Total 2533 25 5 2a 0 1.2% (30)
Table 5 Concordance of  RDTs and  slide positive samples 
compared to nPCR by region, 2015 EMIS
Region Percent concordant, % (n/N)
RDT versus PCR Slide versus PCR
Benishangul-Gumuz 90.7% (39/43) 86.7% (13/15)
Amhara 64.3% (9/14) 77.8% (9/7)
Tigray 68.8% (11/16) 71.4% (7/5)
Total 80.8% (59/73) 83.9% (26/31)
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Studies in The Gambia [40], Thailand [35], Peru [41] 
and Ethiopia [17] showed even low-density, asymp-
tomatic infections could be infectious to mosquitoes, 
which may pose a potential, unidentified reservoir for 
malaria transmission. A recent review [19] summa-
rized that lower density of parasites were seen in low 
transmission compared to high transmission settings 
and argued that subpatent infections contribute to the 
infectious reservoir, could be long-lasting, and predic-
tive of future periods of patent infections.
Several new tools are being developed with higher lim-
its of parasite detection in field settings, such as, ultrasen-
sitive RDTs and loop-mediated isothermal amplification 
(LAMP) [35, 42]. The current study used a sample pool-
ing methodology that decreases cost and time and is 
applicable to screening large number of samples, par-
ticularly from low transmission settings [22, 43]. The low 
blood volume eluted from the DBSs in the current study 
may limit parasite detection as the volume of blood ana-
lysed is critical in determining its limit of detection [44, 
45]. Although more sensitive molecular methods have 
been developed [46], the cost and feasibility of the tests 
in field settings could limit their wide-scale adoption and 
uptake in resource-limited countries.
Conclusion
The current study reports the presence of subpatent 
infection in the samples collected as part of a national 
cross-sectional malaria survey in 2015. Using nPCR, 
the detection of malaria parasites increased by nearly 
threefold over rates compared to microscopy. Subpatent 
infections could potentially be infective to mosquitoes 
contributing to ongoing malaria transmission. Malaria 
elimination efforts may need to consider low-density, 
subpatent infections in managing sources of infectious 
reservoirs or hotspots, in addition to strengthening rou-
tine surveillance and response systems.
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